← All trials
NCT00058201
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2001
- Primary completion
- Apr 1, 2008
- Completion date
- Sep 1, 2010
- First posted
- —
- Last posted
- —
- Enrollment
- 1030
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Royal Liverpool & Broadgreen University Hospitals NHS TrutsLead sponsor
- Australasian Gastro-Intestinal Trials GroupCollaborator
- Canadian Cancer Trials GroupCollaborator
- Flinders UniversityOfficial
- Royal Liverpool & Broadgreen University Hospitals NHS TrutsStudy chair
- University of TorontoStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.